Treatment of hepatocellular carcinoma smaller than 5 cm by transcatheter arterial chemoembolization.

M. Y. Hsieh; S. C. Chen; S. N. Lu; L. Y. Wang; J. F. Tsai; W. L. Chuang; Z. Y. Lin; W. Y. Chang

Treatment of hepatocellular carcinoma smaller than 5 cm by transcatheter arterial chemoembolization.

M. Y. Hsieh^*, S. C. Chen, S. N. Lu, L. Y. Wang, J. F. Tsai, W. L. Chuang, Z. Y. Lin, W. Y. Chang

^*Corresponding author for this work

Kaohsiung Medical University

Research output: Contribution to journal › Journal Article › peer-review

6 Scopus citations

Abstract

To assess the effectiveness of transcatheter arterial chemoembolization (TACE) in the treatment of small hepatocellular carcinoma (HCC) and to analyze the prognostic factors, a total of 77 patients with histologically proven HCC, < or = 5 cm in diameter, were enrolled for the study and followed for more than 2 years, The overall cumulative 1-, 2-, and 3-year survival rates were 79.2%, 50.6% and 36.7%, respectively. The median survival time of Child-Pugh's A patients was 990 +/- 146 days, which was significantly better than the median survival time of Child-Pugh's B patients (450 +/- 82 days) Furthermore, positive HBeAg and alpha-Fetoprotein (AFP) were factors close to statistically significant. In contrast, sex, age, HBsAg, Anti-HCV, tumor type, tumor size and tumor number were not related to the prognosis in small HCC who received TACE.

Original language	English
Pages (from-to)	274-278
Number of pages	5
Journal	Kaohsiung Journal of Medical Sciences
Volume	12
Issue number	5
State	Published - 05 1996
Externally published	Yes

Cite this

@article{d4ea6b93409e4dafa2362f062620a3a0,

title = "Treatment of hepatocellular carcinoma smaller than 5 cm by transcatheter arterial chemoembolization.",

abstract = "To assess the effectiveness of transcatheter arterial chemoembolization (TACE) in the treatment of small hepatocellular carcinoma (HCC) and to analyze the prognostic factors, a total of 77 patients with histologically proven HCC, < or = 5 cm in diameter, were enrolled for the study and followed for more than 2 years, The overall cumulative 1-, 2-, and 3-year survival rates were 79.2%, 50.6% and 36.7%, respectively. The median survival time of Child-Pugh's A patients was 990 +/- 146 days, which was significantly better than the median survival time of Child-Pugh's B patients (450 +/- 82 days) Furthermore, positive HBeAg and alpha-Fetoprotein (AFP) were factors close to statistically significant. In contrast, sex, age, HBsAg, Anti-HCV, tumor type, tumor size and tumor number were not related to the prognosis in small HCC who received TACE.",

author = "Hsieh, {M. Y.} and Chen, {S. C.} and Lu, {S. N.} and Wang, {L. Y.} and Tsai, {J. F.} and Chuang, {W. L.} and Lin, {Z. Y.} and Chang, {W. Y.}",

year = "1996",

month = may,

language = "英语",

volume = "12",

pages = "274--278",

journal = "Kaohsiung Journal of Medical Sciences",

issn = "1607-551X",

publisher = "John Wiley and Sons Inc",

number = "5",

}

TY - JOUR

T1 - Treatment of hepatocellular carcinoma smaller than 5 cm by transcatheter arterial chemoembolization.

AU - Hsieh, M. Y.

AU - Chen, S. C.

AU - Lu, S. N.

AU - Wang, L. Y.

AU - Tsai, J. F.

AU - Chuang, W. L.

AU - Lin, Z. Y.

AU - Chang, W. Y.

PY - 1996/5

Y1 - 1996/5

N2 - To assess the effectiveness of transcatheter arterial chemoembolization (TACE) in the treatment of small hepatocellular carcinoma (HCC) and to analyze the prognostic factors, a total of 77 patients with histologically proven HCC, < or = 5 cm in diameter, were enrolled for the study and followed for more than 2 years, The overall cumulative 1-, 2-, and 3-year survival rates were 79.2%, 50.6% and 36.7%, respectively. The median survival time of Child-Pugh's A patients was 990 +/- 146 days, which was significantly better than the median survival time of Child-Pugh's B patients (450 +/- 82 days) Furthermore, positive HBeAg and alpha-Fetoprotein (AFP) were factors close to statistically significant. In contrast, sex, age, HBsAg, Anti-HCV, tumor type, tumor size and tumor number were not related to the prognosis in small HCC who received TACE.

AB - To assess the effectiveness of transcatheter arterial chemoembolization (TACE) in the treatment of small hepatocellular carcinoma (HCC) and to analyze the prognostic factors, a total of 77 patients with histologically proven HCC, < or = 5 cm in diameter, were enrolled for the study and followed for more than 2 years, The overall cumulative 1-, 2-, and 3-year survival rates were 79.2%, 50.6% and 36.7%, respectively. The median survival time of Child-Pugh's A patients was 990 +/- 146 days, which was significantly better than the median survival time of Child-Pugh's B patients (450 +/- 82 days) Furthermore, positive HBeAg and alpha-Fetoprotein (AFP) were factors close to statistically significant. In contrast, sex, age, HBsAg, Anti-HCV, tumor type, tumor size and tumor number were not related to the prognosis in small HCC who received TACE.

UR - http://www.scopus.com/inward/record.url?scp=0030139926&partnerID=8YFLogxK

M3 - 文章

C2 - 8676432

AN - SCOPUS:0030139926

SN - 1607-551X

VL - 12

SP - 274

EP - 278

JO - Kaohsiung Journal of Medical Sciences

JF - Kaohsiung Journal of Medical Sciences

IS - 5

ER -

Treatment of hepatocellular carcinoma smaller than 5 cm by transcatheter arterial chemoembolization.

Abstract

Other files and links

Fingerprint

Cite this